FTO has been shown to promote the occurrence of insulin defect-related AD by decreasing the TSC1 (TSC Complex Subunit 1) mRNA level, activating the mTOR signaling pathway, and promoting the phosphorylation of tau protein. Here, MAPT is linked to Alzheimer disease.